# A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804

> **NCT01313793** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Treatment A-B
- **DRUG:** Treatment B-A

## Key facts

- **NCT ID:** NCT01313793
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01313793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01313793, "A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01313793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*